Ubiquitin-proteasome-mediated degradation of Id1 is modulated by MyoD

Julie S. Traasch-Azar, Jody Lingbeck, Aaron Ciechanover, Alan L. Schwartz

Research output: Contribution to journalArticle

42 Scopus citations

Abstract

Degradation of many short-lived cellular proteins such as the transcription factor MyoD occurs via the ubiquitin-proteasome pathway. MyoD, similar to many rapidly degraded regulatory factors, interacts with several high affinity binding partners, including members of the Id (inhibitors of DNA binding) family. Following transfection to HeLa cells, Id1 is localized to the nucleus and rapidly (t1/2 ∼ 1 h) degraded via the ubiquitin-proteasome system. Mutagenesis of lysine residues within the putative nuclear localization region (amino acids 68-82) directs Id1NLS to the cytoplasm yet confers an increased rate of degradation (t1/2 ∼ 0.5 h). Id1 in which all lysine residues were mutagenized to alanine (lysineless Id1) was also rapidly degraded (t1/2, ∼ 0.6 h). Addition of a Myc6 tag to the N terminus of lysine-less Id1 markedly stabilized Id1 (t 1/2 > 10 h) and suggests degradation via the N terminus-dependent pathway. Co-transfection of MyoD with Id1 or Id1NLS increases Id1 or Id1NLS within the nucleus and markedly reduces the rate of Id1 or Id1NLS degradation. These results thus demonstrate that in vivo MyoD modulates the rate of Id1 degradation and suggest a dynamic interplay of these factors.

Original languageEnglish
Pages (from-to)32614-32619
Number of pages6
JournalJournal of Biological Chemistry
Volume279
Issue number31
DOIs
StatePublished - Jul 30 2004

Fingerprint Dive into the research topics of 'Ubiquitin-proteasome-mediated degradation of Id1 is modulated by MyoD'. Together they form a unique fingerprint.

  • Cite this